RAP 0.00% 20.5¢ resapp health limited

Ann: 2019 Letter to Shareholders, page-96

  1. 2,084 Posts.
    lightbulb Created with Sketch. 179
    Rapid times...
    Not one deal done yet.
    Will be Interesting to see what year the first deal in Australia and Europe will be finalized.
    I will hold for the long term regardless of FDA.
    This company should bring in good revenue in Australia and Europe alone...
    I have a feeling USA don't want to award FDA to RAP. If this was US company would allready been done and dusted.
    AGM tomorrow
    We wait...
 
watchlist Created with Sketch. Add RAP (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.